Profil

Absil Lara

Main Referenced Co-authors
NONCLERCQ, Denis  (18)
JOURNE, Fabrice  (17)
laurent, guy (5)
Body, Jean-Jacques (4)
SAUSSEZ, Sven  (4)
Main Referenced Disciplines
Immunology & infectious disease (17)
Oncology (4)
Biochemistry, biophysics & molecular biology (2)

Publications (total 19)

The most downloaded
16 downloads
Valentini, X., Absil, L., laurent, G., Robbe, A., Laurent, S., Muller, R., Legrand, A., & Nonclercq, D. (30 January 2017). Toxicity of TiO2 nanoparticules on the NRK52E renal cell line. Molecular and Cellular Toxicology, 13, 419-431. doi:10.1007/s13273-017-0046-1 https://hdl.handle.net/20.500.12907/4837

The most cited

14 citations (Scopus®)

Valentini, X., Absil, L., laurent, G., Robbe, A., Laurent, S., Muller, R., Legrand, A., & Nonclercq, D. (30 January 2017). Toxicity of TiO2 nanoparticules on the NRK52E renal cell line. Molecular and Cellular Toxicology, 13, 419-431. doi:10.1007/s13273-017-0046-1 https://hdl.handle.net/20.500.12907/4837

Absil, L., Rigaux, E., Tafforeau, L., Body, J.-J., Nonclercq, D., & Journe, F. (01 April 2021). Involvement of FXR in the OPG/RANKL pathway of breast and prostate cancer cells. Bone Reports, 14, 101036. doi:10.1016/j.bonr.2021.101036
Peer Reviewed verified by ORBi

Absil, L., Journe, F., Larsimont, D., Body, J.-J., Tafforeau, L., & Nonclercq, D. (10 July 2020). Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells. BMC Cancer, 20, 640. doi:10.1186/s12885-020-07106-7
Peer Reviewed verified by ORBi

Absil, L., Journe, F., & Nonclercq, D. (13 September 2018). Role of the farnesoid X receptor in the osteotropism of breast cancer cells [Paper presentation]. GIGA - cancer days 2018, Liège, Belgium.

Absil, L., Journe, F., & Nonclercq, D. (08 June 2018). The role of FXR in the osteomimetism in MCF-7 Breast Cancer Cells [Poster presentation]. Belgian Society for Cell and Development Biology, Liège, Belgium.

Absil, L., Journe, F., & Nonclercq, D. (27 March 2018). The role of FXR in the osteomimetism in MCF-7 Breast Cancer Cells [Poster presentation]. Mardi des Chercheurs (MdC2018), Valenciennes, France.

Absil, L., Journe, F., & Nonclercq, D. (07 March 2018). Implication du FXR dans l'ostéomimétisme des cellules cancéreuses mammaires MCF-7 [Paper presentation]. Journée doctorale transfrontalière, Reims, France.

Absil, L., Journe, F., & Nonclercq, D. (01 February 2018). The role of FXR in the osteomimetism in MCF-7 Breast Cancer Cells [Poster presentation]. télévie Cancer Seminar, Bruxelles (Erasme), Belgium.

Absil, L., Journe, F., & Nonclercq, D. (07 November 2017). Osteotropism induced by CDCA is interfered by lithocholic acid in breast cancer [Paper presentation]. European Gynecological Oncology Congress, Vienna, Austria.

Absil, L., Journe, F., & Nonclercq, D. (18 May 2017). Osteotropism in MCF-7 Breast Cancer Cells [Poster presentation]. BIT's 10th Annual World Cancer Congress 2017, Barcelona, Spain.

Absil, L., Journe, F., Saussez, S., & Nonclercq, D. (07 March 2017). Chenodeoxycholic acid (CDCA) promotes osteomimetism in MDA-MB-231 cells [Poster presentation]. Huitième édition montoise du MdC : le Mardi des Chercheurs 2017, UMons, Belgium.

Valentini, X., Absil, L., laurent, G., Robbe, A., Laurent, S., Muller, R., Legrand, A., & Nonclercq, D. (30 January 2017). Toxicity of TiO2 nanoparticules on the NRK52E renal cell line. Molecular and Cellular Toxicology, 13, 419-431. doi:10.1007/s13273-017-0046-1
Peer reviewed

Absil, L., Journe, F., Saussez, S., & Nonclercq, D. (08 December 2016). Bile acids promote osteomimetism in MDA-MB-231 cells [Poster presentation]. télévie's Researchers Seminar, UCL Bruxelles, Belgium.

Valentini, X., Absil, L., laurent, G., Frau, A., Rugira Uwamahoro, P., & Nonclercq, D. (08 September 2016). Study of the oxidative stress caused by the exposure to TiO2 nanoparticles in vitro and in vivo [Poster presentation]. RBSM Golden Jubilee Meeting of the Royal Belgium Society for Microscopy, Bruxelles, Belgium.

Absil, L., Journe, F., laurent, G., Larsimont, D., Saussez, S., Body, J.-J., & Nonclercq, D. (08 September 2016). Bile acids and estrogens promote the cell proliferation and osteomimetism in MCF-7 cells [Poster presentation]. RBSM Golden Jubilee Meeting of the Royal Belgium Society for Microscopy, Bruxelles, Belgium.

Absil, L., Journe, F., laurent, G., Larsimont, D., Saussez, S., Body, J.-J., & Nonclercq, D. (01 July 2016). Farnesoid X receptor expression predicts bone metastases from breast cancer [Poster presentation]. Opening Symposium of the ULB- cancer research centre, Brussels, Belgium.

Absil, L., Journe, F., & Nonclercq, D. (27 May 2016). FXR is involved in the control of cell proliferation in breast cancer cells [Poster presentation]. Stem Cells as Disease Model and for Gene Therapy, Brussels, Belgium.

Absil, L., Journe, F., & Nonclercq, D. (18 May 2016). Implication du FXR dans la prolifération cellulaire des cellules de carcinomes mammaires [Poster presentation]. Matinée des chercheurs, Valenciennes, Université de Valenciennes et du Hainaut Cambrésis, France.

Absil, L., Journe, F., laurent, G., Frau, A., Ghanem, G., & Nonclercq, D. (30 January 2016). Phenotypic variations associated to V600EBRAF mutation among metastatic melanoma cell lines [Poster presentation]. BACR Annual Meeting, ULB Erasme, Belgium.

Journe, F., Wiedig, M., Monrandini, R., El Hajj, P., Krayem, M., Sales, F., Theunis, A., Larsimont, D., Absil, L., Laurent, G., Gilot, D., Galibert, M.-D., Awada, A., & Ghanem, G. (08 March 2013). Tyrosine-related protein 1 (TYRP1) expression correlates with markers of both differentiation/pigmentation and proliferation in melanoma [Poster presentation]. Journée des doctorants, Bruxelles, Belgium.

Contact ORBi UMONS